As part of the series,Breaking down diabetes, physician Randall Stafford provides a straightforward guide to medications that can treat Type 2 diabetes.
Tag: medications
Stanford’s new Innovative Medicines Accelerator is already contributing to COVID-19 effort — and much more is planned
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
“Frankly terrifying”: A podcast about drug shortages in the U.S.
In this 1:2:1 podcast, host Paul Costello discusses drug shortages with Stanford and Veterans Affairs anesthesiologist Ed Mariano.
Newborn antibiotic use varies widely, worrying experts
Rates of antibiotic use in newborns vary 27-fold between California hospitals without a medical reason for the large differences, a new study found.
Will antidepressants work? Brain activity can help predict
Using neuroimaging and machine learning, researchers were able to predict whether antidepressants would help individual patients.
Aspirin for prevention: A look at the potential benefits and risks
This is the first in a series of three blog posts on aspirin for prevention. It clarifies the potential benefits and harms of aspirin use.
A promising new anesthetic — discovered with help from a computer
Using drug-designing software, Stanford researchers found a new anesthetic that appears to work while maintaining blood pressure.
Pharmacogenomics syncs medications with an individual’s genetics through Humanwide
Through the Humanwide project, a patient's pharmacogenomic evaluation helped doctors prescribe a pain reliever that is effective for her individual biology.
Proceed carefully with ketamine, Stanford researcher says
In a recent commentary, Alan Schatzberg speaks out about the potential harms, and many questions, that surround ketamine's use to treat depression.
On the importance of culture, partnerships and diversity at the Dean’s Lecture Series
At a recent Dean's Lecture Series, Dean Lloyd Minor discussed organizational culture and diversity with Emma Walmsley, CEO of GlaxoSmithKline.
Promising finding for people with Type 2 diabetes and kidney disease
Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
Existing drug found to dampen chemo side effects in breast cancer — in a dish
Stanford researchers make progress in predicting which patients will suffer heart problems from chemotherapy, and may have found a drug to mitigate them.
Understanding high drug costs and the role of pharmacy benefit managers
Retail prices at pharmacies may bear little relationship to the actual market prices of medications, and pharmacy benefit managers are part of the reason.
Failure to take statins leads to higher mortality
More than a third of patients who are prescribed statins fail to take them regularly, and they are dying at higher rates as a result.
New antibiotics are desperately needed: Machine learning could help
Scientists have created an algorithm that works to generate and refine DNA sequences that are likely to code for antimicrobial proteins.
For patients on antidepressants, a common opioid is less effective
Patients who are taking the most common type of antidepressant may feel more pain when taking certain opioids, Stanford researchers have found.